Our service works in just three simple steps.
Our patient care team is excellent!
Sumatriptan is a medication that falls under the triptan class of drugs. They are commonly prescribed for patients who experience migraines that do not respond to over-the-counter medication. Sumatriptan tablets are usually very effective at stopping migraine symptoms and commonly come in 50mg and 100mg strength.
Sumatriptan is the most common triptan prescribed for migraine in the UK and works very well for most people. The tablets come in 50mg and 100mg, patients are advised to start at the lower strength and move up to 100mg if needed. If after trying the higher strength Sumatriptan still does not work well in stopping your migraines, Rizatripan and Zolmitriptan are also available.
Sumatriptan tablets belong to a group of medication called Triptans. The main mode of action of triptans, is constriction of blood vessels in the brain that cause pain during a migraine. All the effects of Sumatriptan are much more complex and not fully understood. However we do know that Sumatriptan is very effective in relieving the symptoms of migraine in most individuals.
Some potential side effects of Sumatriptan migraine tablets are:
These are usually only temporary and go away on their own after taking Sumatriptan tablets. Be careful not to take too many tablets, as this can lead to more severe side effects. Always follow the directions prescribed for you by the Doctor and consult the Pharmacist if you are unsure.
You should only use your Sumatriptan tablets as prescribed by your Doctor as Sumatriptan overdose can lead to serious side effects. Typically a dose of Sumatriptan should not be repeated for the same migraine and limited to two doses per day and at least 2 hours after the first dose.
Please read the Sumatriptan Patient Leaflet before using this medication.
Before buying medication online, always make sure the website has a green MHRA logo on the bottom of the page. If you can’t find one, then don’t risk it, counterfeit medication is a serious problem in the UK.
Keep up to date with important company news and insights.